Unigene Laboratories designs, manufactures and develops peptide-based therapeutics. The company is building a portfolio of proprietary partnerships in this expanding drug class based on its Peptelligence platform. Unigene
Biosof claims that PubSeq is a novel scientific knowledge management system capable of mining the scientific literature for meaningful, accurate and relevant data. The award was made through
A5 Labs said that the custom-made LIMS system will allow its CRO customers to track and receive real-time information on the progress and status of the analysis of
Medidata Solutions has posted a net income of $4.66m for the third quarter 2010, or $0.2 per diluted share, compared to net income of $1.55m, or $0.06 per
XenoPort has posted a net loss of $19.9m for the third quarter 2010, or $0.65 loss per diluted share, compared to a net loss of $24.37m, or $0.81
The QTDP program was created by Congress as part of the Patient Protection and Affordable Care Act of 2010. NovaBay is a clinical stage biotechnology company focused on
Burris, who will join the company in this capacity on 3 January 2011, is currently a member of the board of directors of OncoGenex. Most recently, Burris worked
Nutrition 21, headquartered in Purchase, NY, is a nutritional bioscience company and holds over 60 issued and pending patents for dietary supplement ingredients, including chromium picolinate and combinations
The Eramune 01 study is an international, multicenter, randomised, non-comparative controlled study of therapeutic intensification plus immunomodulation in HIV-infected patients with long-term viral suppression. Eramune 01 will use
Pfizer’s anti-TNF-alpha Nanobody, ATN-103, is currently in a Phase II study in patients with rheumatoid arthritis (RA) and it has completed recruitment for the Phase II study. Ablynx
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.